Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Become a Member | Sign in
Home>News>This Article

GCT Selects CRO Starter Kit™ PSA Platform by Flex Databases

Published: Thursday, February 13, 2014
Last Updated: Thursday, February 13, 2014
Bookmark and Share
CRO Starter Kit™ provide increased efficiency and speed in running clinical research projects.

Flex Databases has announced that Global Clinical Trials, LLC (GCT) has selected Flex CRO Starter Kit™ as its business automation platform.

GCT is a regional Contract Research Organization (CRO), established in 2001 and headquartered in Princeton, NJ with full-service clinical operations in Russia and Eastern Europe.

"From the very foundation of the company GCT had a clear growth strategy", says Dr. Eugene Selivra, CEO of GCT. "We developed organically, step by step, basing our growth on the experience and knowledge of the management team and efficient business processes. But we always knew a time would come when we would need a software platform to help us handle the increased complexity, size and number of projects. We explored the market in search of a system that would become a core application, driving all of our day-to-day activities. The CRO Starter Kit™ platform became a perfect match for our needs. It has vital tools for a CRO today, such as budget management, eTMF, a Learning Management System, timesheets and more. But above all, CRO Starter Kit™ is a unique platform where ground level operational activities are seamlessly linked to project management, providing increased efficiency and speed in running clinical research projects."

"CRO Starter Kit™ is a platform which brings the company together, creating an environment where every action is interconnected with others", says Timur Galimov, Technical Director of Flex Databases. "Such a system becomes self-reinforcing and is much easier to adopt, because it touches a user from multiple angles. One of the big reasons why CTMS implementations fail is because they affect a limited number of users and become just another database, not connected to anything else and not affecting anything else. The experience and industry knowledge of GCT allowed them to avoid this pitfall by selecting Flex CRO Starter Kit™."

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Flex Databases Launches New Web Site
New website cements the company's unique positioning as a PSA company.
Tuesday, March 25, 2014
Scientific News
Lucentis Effective for Proliferative Diabetic Retinopathy
NIH-funded clinical trial marks first major advance in therapy in 40 years.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Gene Therapy Staves Off Blindness from Retinitis Pigmentosa in Canine Model
NIH-funded study suggests therapeutic window may extend to later-stage disease.
Treatment for Rare Bleeding Disorder is Effective
Researchers in Manchester have demonstrated for the first time the relative safety and effectiveness of treatment, eltrombopag, in children with persistent or chronic immune thrombocytopenia (ITP), as part of an international duo of studies.
HIV Vaccine Human Trials Begin
Baltimore-based Institute has begun enrolling volunteers for initial phase 1 clinical trials.
New Therapy Reduces Symptoms of Inherited Enzyme Deficiency
A phase three clinical trial of a new enzyme replacement medication, sebelipase alfa, showed a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency, an inherited enzyme deficiency that can result in scarring of the liver and high cholesterol.
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos